Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.1 -3.51%
Market Cap
$30.1M
Price Target
Refer to Report
Volume
32.6K
52wk Range
$0.975 - $1.675
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.